What Does the FDA's BPA Decision Mean for Companies?
Richard Liroff | Greenbiz.com
When the Food and Drug Administration earlier this month expressed for the first time some concern about bisphenol A, it no doubt caused some panic among potentially impacted firms — but it also opened the door of opportunity for early movers.
The information in this website was obtained from sources believed to be reliable, however, we cannot guarantee that the information is accurate or complete. The information provided is a general source of information and should not be considered personal investment advice or solicitation to buy or sell securities.
Leede Jones Gable Inc. is a
Member of IIROC and the Canadian Investor Protection Fund
Stephen Whipp is a member of the Responsible Investment Association